PBLA – panbela therapeutics, inc. (US:NASDAQ)

News

Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Panbela Provides Business Update and Reports Q1 2024 Financial Results [Yahoo! Finance]
Panbela Provides Business Update and Reports Q1 2024 Financial Results
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com